BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24909636)

  • 1. Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial.
    Jesam C; Salvatierra AM; Schwartz JL; Fuentes A; Croxatto HB
    Contraception; 2014 Aug; 90(2):168-73. PubMed ID: 24909636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception.
    Jesam C; Salvatierra AM; Schwartz JL; Croxatto HB
    Hum Reprod; 2010 Feb; 25(2):368-73. PubMed ID: 19933235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delay of ovulation by meloxicam in healthy cycling volunteers: A placebo-controlled, double-blind, crossover study.
    Bata MS; Al-Ramahi M; Salhab AS; Gharaibeh MN; Schwartz J
    J Clin Pharmacol; 2006 Aug; 46(8):925-32. PubMed ID: 16855077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception.
    Hester KE; Harper MJ; Duffy DM
    Hum Reprod; 2010 Feb; 25(2):360-7. PubMed ID: 19965877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
    Croxatto HB; Massai MR; Salvatierra AM; Fuentealba B; Croxatto HD; Lähteenmäki P
    Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens.
    Brache V; Cochon L; Deniaud M; Croxatto HB
    Contraception; 2013 Nov; 88(5):611-8. PubMed ID: 23809278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Clinical Treatment with Phenylbutazone and Meloxicam in the Pre-ovulatory Period Influence the Ovulation Rate in Mares?
    Lima AG; Costa LC; Alvarenga MA; Martins CB
    Reprod Domest Anim; 2015 Oct; 50(5):771-5. PubMed ID: 26280558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study.
    Cameron ST; Berger C; Michie L; Klipping C; Gemzell-Danielsson K
    Hum Reprod; 2015 Jul; 30(7):1566-72. PubMed ID: 25994664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility study of Nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception.
    Croxatto HB; Brache V; Massai R; Alvarez F; Forcelledo ML; Pavez M; Cochon L; Salvatierra AM; Faundes A
    Contraception; 2006 Jan; 73(1):46-52. PubMed ID: 16371294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study.
    Pall M; Fridén BE; Brännström M
    Hum Reprod; 2001 Jul; 16(7):1323-8. PubMed ID: 11425807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema.
    Göksel O; Aydin O; Misirligil Z; Demirel YS; Bavbek S
    J Dermatol; 2010 Nov; 37(11):973-9. PubMed ID: 21039786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of interaction between orlistat and oral contraceptives.
    Hartmann D; Güzelhan C; Zuiderwijk PB; Odink J
    Eur J Clin Pharmacol; 1996; 50(5):421-4. PubMed ID: 8839667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation.
    Croxatto HB; Brache V; Pavez M; Cochon L; Forcelledo ML; Alvarez F; Massai R; Faundes A; Salvatierra AM
    Contraception; 2004 Dec; 70(6):442-50. PubMed ID: 15541405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].
    Rossmanith WG; Wirth U; Gasser S; Thun B; Steffens D
    Zentralbl Gynakol; 1997; 119(11):538-44. PubMed ID: 9480608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The COX-2 inhibitor meloxicam prevents pregnancy when administered as an emergency contraceptive to nonhuman primates.
    McCann NC; Lynch TJ; Kim SO; Duffy DM
    Contraception; 2013 Dec; 88(6):744-8. PubMed ID: 24120248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.
    Ruperto N; Nikishina I; Pachanov ED; Shachbazian Y; Prieur AM; Mouy R; Joos R; Zulian F; Schwarz R; Artamonova V; Emminger W; Bandeira M; Buoncompagni A; Foeldvari I; Falcini F; Baildam E; Kone-Paut I; Alessio M; Gerloni V; Lenhardt A; Martini A; Hanft G; Sigmund R; Simianer S;
    Arthritis Rheum; 2005 Feb; 52(2):563-72. PubMed ID: 15692986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.